So a vaccine is being developed for the swine fly (H1N1). Many people are convinced that the H1N1 virus is a pandemic virus that is more aggressive than flu virus’ in the past. It is true that it seems that a high percentage of folks that come in contact with the virus develop symptoms. However, one major fact so often overlooked is that the cases still can be considered mild with percentages of far fewer serious complications from this flu than typical winter influenza. This, my friend, is a mild flu virus that the vast majority of people will recover from completely and rapidly with absolutely no medical intervention.
Why then is there still panic? There are 190 million government ordered doses of a vaccine to combat this viral “bacon.” So the modus operandi is the same. A virus hits the population and a vaccine is ordered to take care of it. What do we know about this vaccine? We know that it is being developed very rapidly leaving very little chance to effectively test for safety or really even efficacy. Although it may appear to be beneficial to push this vaccine through quickly in order to save people the discomfort of an essentially non deadly flu, but what about the long term consequences of an untested vaccine? The limited time for development also means that the actual virus for the vaccine may not be produced in adequate quantities. This can lead the manufacturers to add something to the mix that guarantees that you will have a heightened immune response even if the level of virus injected is very small. In other words they are stretching the short supply. This is what is happening with the H1N1 vaccine.
Again this seems ok as you would most likely want the heightened immune response effect if you are going to receive the vaccine. Let’s consider what this immune response boosting “stuff” is. In the, past things like mercury and aluminum have been commonly used, but those toxins are yesterday’s news. For the “pig virus” we need something new; a hip adjuvant if you will. That new adjuvant is squalene, an oil that is synthetically produced. As a matter of fact the WHO is now recommending this adjuvant as stated on a July 13 briefing on the swine flu pandemic: “In view of the anticipated limited vaccine availability at global level and the potential need to protect against “drifted” strains of virus, SAGE recommended that promoting production and use of vaccines such as those that are formulated with oil-in-water adjuvants and live attenuated influenza vaccines was important.”
Why the big deal? It is good to note there are no approved vaccines in the US that contain the additive squalene. Squalene itself is fine. In fact it is found in many places throughout the body, especially the nervous system. It is not however, found freely floating in your blood. Why? Because when squalene is injected directly into the bloodstream (i.e., vaccine) the body sees it as a toxin and attacks it. This can be a problem for you and a bonus for vaccine makers, as your immune system builds antibodies to this foreign substance in the blood. Good for vaccine companies as your immune system is stimulated; bad for you because now those antibodies turn and attack squalene wherever they are found naturally occurring in your nervous system. This information was obtained after the discovery of squalene in the experimental anthrax vaccine used in Gulf War Veterans. Although the DOD first would not admit that squalene was a component of the vaccine there were to facts to show otherwise. First the FDA found squalene in some tested samples of the vaccine and second an anti-squalene antibody test was developed for patients suffering Gulf War Syndrome (GWS) and a clear link was made between those with GWS and antisqualene antibodies. A study from Tulane university in 2000 that was published in the journal of Experimental Molecular Pathology made it very clear: “ … the substantial majority (95%) of overtly ill deployed GWS patients had antibodies to squalene. All (100%) GWS patients immunized for service in Desert Shield/Desert Storm who did not deploy, but had the same signs and symptoms as those who did deploy, had antibodies to squalene. In contrast, none (0%) of the deployed Persian Gulf veterans not showing signs and symptoms of GWS have antibodies to squalene. Neither patients with idiopathic autoimmune disease nor healthy controls had detectable serum antibodies to squalene. The majority of symptomatic GWS patients had serum antibodies to squalene.”
This would be the first approved in the US vaccine to contain squalene which failed. It is unfortunate that it was used on soldiers. The question now becomes why are we doing this and what long term effects will we see from people having toxins like squalene injected. These questions will bear answers later and with 190 million doses already ordered in the US alone those answers will be repeated over and over and over again.